Adalimumab-ryvk
- Product NDC
- 51759-360
- 11-digit product format
- 517590360
- Labeler code
- 51759
- Product ID
- 51759-360_ed0b2de6-71a4-439f-a464-f7383cf5dd4e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- adalimumab-ryvk
- Dosage form
- KIT
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- BLA761299
- Marketing category
- BLA
- Marketing start
- 2025-07-01
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Adalimumab-ryvk
- Listing expiration
- 2026-12-31
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2d19a877-1f5a-4731-800a-dddadc424080 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| 58819a18-327d-463b-9e5e-26cc1dd9870d | Product name | 1 | 20230313 |
| c1c5a070-0e2e-43dd-af9c-a21585200342 | Product name | 1 | 20230104 |
| 2a463079-cd68-4798-a3d6-55c4c8578d57 | Product name | 1 | 20220728 |
| 652f8f6b-479d-477c-848a-374d5b0145b7 | Product name | 2 | 20151203 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51759-360-02 | Adalimumab-ryvk | 1 in 1 KIT | KIT | 1 | 7 | |
| 51759-360-02 | Adalimumab-ryvk | 2 in 1 CARTON | KIT | 2 | 7 | |
| 51759-368-21 | Adalimumab-ryvk | 0.4 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.4 mL | 40 mg in 0.4mL | 7 |
| 65517-0002-1 | Adalimumab-ryvk | 0.4 mL in 1 POUCH | SWAB | 0.4 mL | 0.7 mL in 1mL | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51759-360-02 | EA - Each | 51759-360 | 32bd744e-7e6e-4094-9435-e55ab0cc5056 | 1 | 2025-10-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Adalimumab-ryvk | ADALIMUMAB-RYVK | Teva Pharmaceuticals USA, Inc. | f8c0d3c2-b5ed-4bb8-927c-5c5529343ee6 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | BLA761299 |
| Adalimumab-ryvk | ADALIMUMAB-RYVK | Quallent Pharmaceuticals Health LLC | dce1590f-9e47-4c4d-9437-cfb18b779a75 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | BLA761299 |
| Adalimumab-ryvk | ADALIMUMAB-RYVK | Teva Pharmaceuticals USA, Inc. | 2d19a877-1f5a-4731-800a-dddadc424080 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | BLA761299 51759-360 |
| Simlandi | ADALIMUMAB-RYVK | Teva Pharmaceuticals USA, Inc. | 12f609c9-2088-bb05-e063-6394a90a9ecc | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | BLA761299 |
| Simlandi | ADALIMUMAB-RYVK | A-S Medication Solutions | ba9dd71c-13c9-4cfe-84a2-b4f17d1c583f | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | BLA761299 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761299 | Simlandi | adalimumab-ryvk | 351(k) Interchangeable | Rx | 2026-09-01 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2677780 | adalimumab-ryvk 40 MG in 0.4 ML Auto-Injector | PSN | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
| 2706644 | adalimumab-ryvk 80 MG in 0.8 ML Auto-Injector | PSN | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
| 797544 | isopropyl alcohol 70 % Medicated Pad | PSN | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
| 2677780 | 0.4 ML adalimumab-ryvk 100 MG/ML Auto-Injector | SCD | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
| 2706644 | 0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector | SCD | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
| 797544 | isopropyl alcohol 0.7 ML/ML Medicated Pad | SCD | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
| 2677780 | adalimumab-ryvk 40 MG per 0.4 ML Auto-Injector | SY | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
| 2706644 | adalimumab-ryvk 80 MG per 0.8 ML Auto-Injector | SY | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
| 797544 | isopropyl alcohol 70 % Medicated Pad | SY | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
| 797544 | isopropyl alcohol 70 % Topical Cloth | SY | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
| 797544 | isopropyl alcohol 70 % Topical Swab | SY | 2d19a877-1f5a-4731-800a-dddadc424080 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 51759-360-02 | 51759036002 | 2 KIT in 1 CARTON (51759-360-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-368-21) * .4 mL in 1 POUCH (65517-0002-1) | 2 kit | 2025-07-01 | No | No | Current |
| 51759-368-21 | 51759036821 | 0.4 mL in 1 SYRINGE | 0.4 ml | Historical | |||
| 65517-0002-1 | 65517000201 | 0.4 mL in 1 POUCH | 0.4 ml | Historical |